Densitometric simultaneous estimation of combination of empagliflozin, linagliptin and metformin hydrochloride used in the treatment of type 2 diabetes mellitus
Crossref DOI link: https://doi.org/10.1007/s00764-020-00026-z
Published Online: 2020-05-06
Published Print: 2020-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patel, Ishita M.
Chhalotiya, Usmangani K.
Jani, Harsha D.
Kansara, Devansh
Shah, Dimal A
Text and Data Mining valid from 2020-04-01
Version of Record valid from 2020-04-01
Article History
Received: 29 January 2020
Accepted: 6 April 2020
First Online: 6 May 2020